| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fluphenazine | androgen receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| fluphenazine | androgen receptor | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | unknown |
| fluphenazine | calmodulin | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| fluphenazine | calmodulin | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | inhibitor |
| fluphenazine | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.21 | approved | antagonist |
| fluphenazine | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.21 | approved | antagonist |
| fluphenazine | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved | antagonist |
| fluphenazine | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.17 | approved | antagonist |
| fluphenazine | 5-ht 1b receptor | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | approved | unknown |
| fluphenazine | 5-ht 1b receptor | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.07 | approved | unknown |
| fluphenazine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.06 | approved | antagonist |
| fluphenazine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved | antagonist |
| fluphenazine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Middle East Respiratory Syndrome[MeSHID:D018352] |
NA | approved | unknown |
| fluphenazine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| click here to return to the previous page | ||||||||